STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5
Summary: Loss of midbrain dopaminergic (mDA) neurons and their axons is central to Parkinson's disease (PD). Growth differentiation factor (GDF)5 is a potential neurotrophic factor for PD therapy. However, the molecular mediators of its neurotrophic action are unknown. Our proteomics analysis s...
Main Authors: | Jayanth Anantha, Susan R. Goulding, Sean L. Wyatt, Ruth M. Concannon, Louise M. Collins, Aideen M. Sullivan, Gerard W. O'Keeffe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004220306490 |
Similar Items
-
Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
by: Susan R Goulding, et al.
Published: (2022-01-01) -
The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
by: Susan R Goulding, et al.
Published: (2020-01-01) -
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling
by: Martina Mazzocchi, et al.
Published: (2019-09-01) -
Neurotrophic factor therapy for Parkinson′s disease: past, present and future
by: Aideen M Sullivan, et al.
Published: (2016-01-01) -
Regulation of neurite growth by tumour necrosis superfamily member RANKL
by: Humberto Gutierrez, et al.
Published: (2013-01-01)